Literature DB >> 27938950

Pterygium excision with conjunctival autograft and subconjunctival amniotic membrane as antirecurrence agents.

Alexander Shusko, John A Hovanesian.   

Abstract

OBJECTIVE: To determine the outcome of pterygium excision with a conjunctival autograft when the adjunctive use of a subconjunctival graft of amniotic membrane is employed to reduce fibrosis and recurrence after surgery.
DESIGN: This is a retrospective, noncomparative study of postoperative outcomes. PARTICIPANTS: Eighty-four patients totalling 101 eyes with clinically significant pterygia that warranted surgical excision.
METHODS: Surgeries were performed at South Orange County Outpatient Surgery Center (San Clemente, Calif.) between June 6, 2006, and October 23, 2013, by a single surgeon (J.A.H.). Patients were included in the study according to the need for pterygium surgery and the type of surgery performed. Exclusion criteria included patients with recurrent pterygium, those with pseudopterygium, and those whose treatment plan included prophylactic mitomycin during or after surgery. Initial pterygia measurements and postoperative findings were taken through standard slit-lamp examinations.
RESULTS: Pterygium recurrence was defined as growth greater than 1 mm onto the corneal limbus at or after 6 months. There was 1 case of pterygium recurrence for a recurrence rate of 0.99% ± 1.93% (n = 101, p = 0.05). The mean extent of preoperative horizontal encroachment of pterygium on the cornea was 2.4 ± 0.87 mm.
CONCLUSIONS: Pterygium excision with a conjunctival autograft and prophylactic placement of a subconjunctival amniotic membrane graft has a low recurrence rate with minimal added surgical time and minimal added risk to the patient and has merit as a surgical technique.
Copyright © 2016 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27938950     DOI: 10.1016/j.jcjo.2016.02.022

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  4 in total

1.  Identification and differentiation therapy strategy of pterygium in vitro.

Authors:  Xinyuan Hu; Nitin Tandra; Zhijian Zhang; Aihua Gong; Jingyan Chen; Yang Li; Qian Chen; Wenrong Xu; Hui Qian
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Pterygium Surgery Utilizing Limbal Conjunctival Autograft and Subconjunctival Amniotic Membrane Graft in High-Risk Populations.

Authors:  Alexander Shusko; Barry A Schechter; John A Hovanesian
Journal:  Clin Ophthalmol       Date:  2020-07-23

3.  Biomechanical Modeling of Pterygium Radiation Surgery: A Retrospective Case Study.

Authors:  Bojan Pajic; Daniel M Aebersold; Andreas Eggspuehler; Frederik R Theler; Harald P Studer
Journal:  Sensors (Basel)       Date:  2017-05-24       Impact factor: 3.576

4.  Outcomes of Vertical Split Conjunctival Autograft Using Fibrin Glue in Treatment of Primary Double-Headed Pterygia.

Authors:  Tarek Roshdy Elhamaky; Ahmed Mohammed Elbarky
Journal:  J Ophthalmol       Date:  2018-12-20       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.